Impact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Impact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis : a prospective multinational cohort study. / Jansana, Anna; Auguste, Aviane; Kvaskoff, Marina; Fournier, Agnès; Fontvieille, Emma; Peruchet-Noray, Laia; Biessy, Carine; Cordova, Reynalda; Nielsen Petersen, Kristina Elin; Tjønneland, Anne; Katzke, Verena; Kaaks, Rudolf; Ricceri, Fulvio; Panico, Salvatore; Contiero, Paolo; Sánchez, Maria-Jose; Castilla, Jesus; Crous-Bou, Marta; Heath, Alicia; Aglago, Elom Kouassivi; Weiderpass, Elisabete; Gunter, Marc James; Ferrari, Pietro; Riboli, Elio; Viallon, Vivian; Freisling, Heinz.

In: Cancer communications (London, England), 2024.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Jansana, A, Auguste, A, Kvaskoff, M, Fournier, A, Fontvieille, E, Peruchet-Noray, L, Biessy, C, Cordova, R, Nielsen Petersen, KE, Tjønneland, A, Katzke, V, Kaaks, R, Ricceri, F, Panico, S, Contiero, P, Sánchez, M-J, Castilla, J, Crous-Bou, M, Heath, A, Aglago, EK, Weiderpass, E, Gunter, MJ, Ferrari, P, Riboli, E, Viallon, V & Freisling, H 2024, 'Impact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study', Cancer communications (London, England). https://doi.org/10.1002/cac2.12526

APA

Jansana, A., Auguste, A., Kvaskoff, M., Fournier, A., Fontvieille, E., Peruchet-Noray, L., Biessy, C., Cordova, R., Nielsen Petersen, K. E., Tjønneland, A., Katzke, V., Kaaks, R., Ricceri, F., Panico, S., Contiero, P., Sánchez, M-J., Castilla, J., Crous-Bou, M., Heath, A., ... Freisling, H. (2024). Impact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study. Cancer communications (London, England). https://doi.org/10.1002/cac2.12526

Vancouver

Jansana A, Auguste A, Kvaskoff M, Fournier A, Fontvieille E, Peruchet-Noray L et al. Impact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study. Cancer communications (London, England). 2024. https://doi.org/10.1002/cac2.12526

Author

Jansana, Anna ; Auguste, Aviane ; Kvaskoff, Marina ; Fournier, Agnès ; Fontvieille, Emma ; Peruchet-Noray, Laia ; Biessy, Carine ; Cordova, Reynalda ; Nielsen Petersen, Kristina Elin ; Tjønneland, Anne ; Katzke, Verena ; Kaaks, Rudolf ; Ricceri, Fulvio ; Panico, Salvatore ; Contiero, Paolo ; Sánchez, Maria-Jose ; Castilla, Jesus ; Crous-Bou, Marta ; Heath, Alicia ; Aglago, Elom Kouassivi ; Weiderpass, Elisabete ; Gunter, Marc James ; Ferrari, Pietro ; Riboli, Elio ; Viallon, Vivian ; Freisling, Heinz. / Impact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis : a prospective multinational cohort study. In: Cancer communications (London, England). 2024.

Bibtex

@article{a4e374b085f14264857a4df05b3c64fd,
title = "Impact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study",
abstract = "Owing to shared risk factors between cardiometabolic diseases (CMDs) and cancer, coupled with population aging, the lifetime risk of an individual developing cancer after a CMD is increasing. Furthermore, biological mechanisms such as insulin resistance or inflammation may not only predispose individuals with CMD to an elevated risk of certain types of cancer but also to a diagnosis of cancer at an advanced stage",
author = "Anna Jansana and Aviane Auguste and Marina Kvaskoff and Agn{\`e}s Fournier and Emma Fontvieille and Laia Peruchet-Noray and Carine Biessy and Reynalda Cordova and {Nielsen Petersen}, {Kristina Elin} and Anne Tj{\o}nneland and Verena Katzke and Rudolf Kaaks and Fulvio Ricceri and Salvatore Panico and Paolo Contiero and Maria-Jose S{\'a}nchez and Jesus Castilla and Marta Crous-Bou and Alicia Heath and Aglago, {Elom Kouassivi} and Elisabete Weiderpass and Gunter, {Marc James} and Pietro Ferrari and Elio Riboli and Vivian Viallon and Heinz Freisling",
year = "2024",
doi = "10.1002/cac2.12526",
language = "English",
journal = "Cancer communications (London, England)",
issn = "2523-3548",
publisher = "Wiley",

}

RIS

TY - JOUR

T1 - Impact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis

T2 - a prospective multinational cohort study

AU - Jansana, Anna

AU - Auguste, Aviane

AU - Kvaskoff, Marina

AU - Fournier, Agnès

AU - Fontvieille, Emma

AU - Peruchet-Noray, Laia

AU - Biessy, Carine

AU - Cordova, Reynalda

AU - Nielsen Petersen, Kristina Elin

AU - Tjønneland, Anne

AU - Katzke, Verena

AU - Kaaks, Rudolf

AU - Ricceri, Fulvio

AU - Panico, Salvatore

AU - Contiero, Paolo

AU - Sánchez, Maria-Jose

AU - Castilla, Jesus

AU - Crous-Bou, Marta

AU - Heath, Alicia

AU - Aglago, Elom Kouassivi

AU - Weiderpass, Elisabete

AU - Gunter, Marc James

AU - Ferrari, Pietro

AU - Riboli, Elio

AU - Viallon, Vivian

AU - Freisling, Heinz

PY - 2024

Y1 - 2024

N2 - Owing to shared risk factors between cardiometabolic diseases (CMDs) and cancer, coupled with population aging, the lifetime risk of an individual developing cancer after a CMD is increasing. Furthermore, biological mechanisms such as insulin resistance or inflammation may not only predispose individuals with CMD to an elevated risk of certain types of cancer but also to a diagnosis of cancer at an advanced stage

AB - Owing to shared risk factors between cardiometabolic diseases (CMDs) and cancer, coupled with population aging, the lifetime risk of an individual developing cancer after a CMD is increasing. Furthermore, biological mechanisms such as insulin resistance or inflammation may not only predispose individuals with CMD to an elevated risk of certain types of cancer but also to a diagnosis of cancer at an advanced stage

U2 - 10.1002/cac2.12526

DO - 10.1002/cac2.12526

M3 - Journal article

C2 - 38487965

JO - Cancer communications (London, England)

JF - Cancer communications (London, England)

SN - 2523-3548

ER -

ID: 386143192